Apogee Therapeutics, Inc. announced its financial results for the quarter and year ended December 31, 2023, and positive initial Phase 1 data from its first-in-human study of APG777.
AI Assistant
APOGEE THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.